These results suggest that ZEB1 acts as a key regulator of ALK-TKI tolerance by modulating EMT marker expression and HER3 mediated cell survival signaling in ALK-rearranged NSCLC (Fig. 3f). This evidence concerns the gene ERBB3 and non-small cell lung carcinoma.